These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
134 related articles for article (PubMed ID: 1372260)
1. CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis. Brooimans RA; Van der Ark AA; Tomita M; Van Es LA; Daha MR Eur J Immunol; 1992 Mar; 22(3):791-7. PubMed ID: 1372260 [TBL] [Abstract][Full Text] [Related]
2. Relative roles of decay-accelerating factor, membrane cofactor protein, and CD59 in the protection of human endothelial cells against complement-mediated lysis. Brooimans RA; van Wieringen PA; van Es LA; Daha MR Eur J Immunol; 1992 Dec; 22(12):3135-40. PubMed ID: 1280224 [TBL] [Abstract][Full Text] [Related]
3. Protection of rat endothelial cells from primate complement-mediated lysis by expression of human CD59 and/or decay-accelerating factor. Charreau B; Cassard A; Tesson L; Le Mauff B; Navenot JM; Blanchard D; Lublin D; Soulillou JP; Anegon I Transplantation; 1994 Dec; 58(11):1222-9. PubMed ID: 7527603 [TBL] [Abstract][Full Text] [Related]
4. Protection of porcine aortic endothelial cells from complement-mediated cell lysis and activation by recombinant human CD59. Kennedy SP; Rollins SA; Burton WV; Sims PJ; Bothwell AL; Squinto SP; Zavoico GB Transplantation; 1994 May; 57(10):1494-501. PubMed ID: 7515200 [TBL] [Abstract][Full Text] [Related]
5. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells. Brasoveanu LI; Altomonte M; Fonsatti E; Colizzi F; Coral S; Nicotra MR; Cattarossi I; Cattelan A; Natali PG; Maio M Lab Invest; 1996 Jan; 74(1):33-42. PubMed ID: 8569195 [TBL] [Abstract][Full Text] [Related]
6. Expression and function of CD59 on colonic adenocarcinoma cells. Bjørge L; Vedeler CA; Ulvestad E; Matre R Eur J Immunol; 1994 Jul; 24(7):1597-603. PubMed ID: 7517877 [TBL] [Abstract][Full Text] [Related]
7. Regulation of CD59 expression on the human endothelial cell line EA.hy 926. Meri S; Mattila P; Renkonen R Eur J Immunol; 1993 Oct; 23(10):2511-6. PubMed ID: 7691609 [TBL] [Abstract][Full Text] [Related]
8. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis. Gorter A; Blok VT; Haasnoot WH; Ensink NG; Daha MR; Fleuren GJ Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608 [TBL] [Abstract][Full Text] [Related]
9. Porcine complement regulators protect aortic smooth muscle cells poorly against human complement-induced lysis and proliferation: consequences for xenotransplantation. Capey S; van den Berg CW Xenotransplantation; 2005 May; 12(3):217-26. PubMed ID: 15807772 [TBL] [Abstract][Full Text] [Related]
10. Effects of complement activation on the expression of CD59 by human mesangial cells. Shibata T; Kohsaka T J Immunol; 1995 Jul; 155(1):403-9. PubMed ID: 7541422 [TBL] [Abstract][Full Text] [Related]
11. Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells. Hakulinen J; Meri S Lab Invest; 1994 Dec; 71(6):820-7. PubMed ID: 7528832 [TBL] [Abstract][Full Text] [Related]
12. The complement-inhibitory activity of CD59 resides in its capacity to block incorporation of C9 into membrane C5b-9. Rollins SA; Sims PJ J Immunol; 1990 May; 144(9):3478-83. PubMed ID: 1691760 [TBL] [Abstract][Full Text] [Related]
13. Transfection of human CD59 complementary DNA into rat cells confers resistance to human complement. Walsh LA; Tone M; Waldmann H Eur J Immunol; 1991 Mar; 21(3):847-50. PubMed ID: 1707009 [TBL] [Abstract][Full Text] [Related]
14. Expression of the complement regulatory protein CD59 on human spermatozoa: characterization and role in gametic interaction. Fenichel P; Cervoni F; Hofmann P; Deckert M; Emiliozzi C; Hsi BL; Rossi B Mol Reprod Dev; 1994 Jul; 38(3):338-46. PubMed ID: 7522480 [TBL] [Abstract][Full Text] [Related]
15. Human oligodendrocytes are not sensitive to complement. A study of CD59 expression in the human central nervous system. Zajicek J; Wing M; Skepper J; Compston A Lab Invest; 1995 Jul; 73(1):128-38. PubMed ID: 7541492 [TBL] [Abstract][Full Text] [Related]
16. Decay-accelerating factor on human umbilical vein endothelial cells. Its histamine-induced expression and spontaneous rapid shedding from the cell surface. Tsuji S; Kaji K; Nagasawa S J Immunol; 1994 Feb; 152(3):1404-10. PubMed ID: 7507966 [TBL] [Abstract][Full Text] [Related]
17. Permanent expression of human CD59 and/or decay-accelerating factor by rat endothelial cells confers protection from human complement-mediated lysis. Charreau B; Cassard A; Tesson L; Le Mauff B; Blanchard D; Lublin D; Soulillou JP; Anegon I Transplant Proc; 1995 Feb; 27(1):336-7. PubMed ID: 7533404 [No Abstract] [Full Text] [Related]
18. Surface expression of complement regulatory proteins, decay-accelerating factor (DAF) and CD59, on cultured human endothelial cells. Kunii H; Shichishima T; Saitoh Y; Noji H; Maruyama Y Fukushima J Med Sci; 1998 Dec; 44(2):69-81. PubMed ID: 10091379 [TBL] [Abstract][Full Text] [Related]
19. Susceptibility of human trophoblast to killing by human complement and the role of the complement regulatory proteins. Tedesco F; Narchi G; Radillo O; Meri S; Ferrone S; Betterle C J Immunol; 1993 Aug; 151(3):1562-70. PubMed ID: 7687635 [TBL] [Abstract][Full Text] [Related]
20. Cytokine-mediated regulation of the surface expression of complement regulatory proteins, CD46(MCP), CD55(DAF), and CD59 on human vascular endothelial cells. Moutabarrik A; Nakanishi I; Namiki M; Hara T; Matsumoto M; Ishibashi M; Okuyama A; Zaid D; Seya T Lymphokine Cytokine Res; 1993 Jun; 12(3):167-72. PubMed ID: 7688580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]